Cerebrospinal Fluid Leak Clinical Trials

Find Cerebrospinal Fluid Leak Clinical Trials Near You

The NoSeal Trial - Nasal Outcome Study Evaluating Artificial Leak-Sealing: A Prospective, Randomized, Controlled, Single-Blinded, Single-Center Clinical Trial Comparing Fibrin Glue (Tisseel®) and a Two-Component Synthetic Polymer Sealant (PEI/PEG, Adherus®) Versus No Sealant for the Prevention of Cerebrospinal Fluid Leak and Promotion of Wound Healing Following Endonasal Skull Base Surgery, Designed in Accordance With the SPIRIT 2025 Guidelines

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Postoperative cerebrospinal fluid (CSF) leak is a significant complication of endoscopic endonasal approaches (EEA) to the skull base. The use of tissue sealants such as fibrin glue (Tisseel) or synthetic agents (PEI/PEG) is widespread in surgical practice, however, recent high-quality evidence challenges their clinical benefit and cost-effectiveness. This study aims to investigate whether the routine use of sealants in patient with peri-operatively assessed low CSF leak risk, significantly improves outcomes over no sealant use, to guide more cost- effective, evidence-based closure strategies. To the best of our knowledge, the present study is the first randomized clinical trial to evaluate the necessity and comparative effectiveness of fibrin and synthetic sealants versus no sealant in preventing postoperative CSF leaks following endoscopic endonasal surgery in low-post operative CSF leak risk patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥ 18 years

• Scheduled for endoscopic endonasal surgery involving standard skull base reconstruction

• Informed written consent obtained prior to enrollment

• Hemodynamic and electrolyte stability before surgery

• Procedure expected to be completed without use of high-flow intraoperative CSF diversion techniques

Locations
Other Locations
Poland
Maria Sklodowska-Curie Institute - Oncology Center
RECRUITING
Warsaw
Contact Information
Primary
Wojciech Czyzewski, MD PhD, MD PhD
wojciech.w.czyzewski@gmail.com
+48788599550
Time Frame
Start Date: 2025-08-15
Estimated Completion Date: 2027-03-15
Participants
Target number of participants: 225
Treatments
Experimental: No Sealant - Standard Multilayer Closure
Patients in this arm will receive standard multilayer closure without the use of any sealant. Closure will involve mucosal flap repositioning and hemostatic agents (e.g., Surgicel®, TachoSil®), in accordance with standard endoscopic skull base reconstruction techniques.
Experimental: Fibrin Glue - Tisseel® Application
Patients will undergo standard multilayer closure followed by application of fibrin sealant (Tisseel®). This arm evaluates the effect of biologic tissue glue in preventing postoperative CSF leaks and promoting wound healing following endonasal skull base surgery.
Experimental: Synthetic Sealant - Adherus® Application
This arm involves standard multilayer closure followed by the application of a two-component synthetic polyethylene glycol-based sealant (Adherus®). The objective is to evaluate the synthetic agent's efficacy and cost-effectiveness in reducing postoperative CSF leaks.
Related Therapeutic Areas
Sponsors
Leads: Maria Sklodowska-Curie National Research Institute of Oncology

This content was sourced from clinicaltrials.gov